90 related articles for article (PubMed ID: 5422144)
1. [Chemistry of 9,9-dioxopromethazine (Prothanon)].
Wunderlich H; Stark A
Pharmazie; 1970 Feb; 25(2):78-83. PubMed ID: 5422144
[No Abstract] [Full Text] [Related]
2. [Biotransformation of 9,9-dioxopromethazine (Prothanon)].
Stade K; Wunderlich H; Stark A
Pharmazie; 1970 Feb; 25(2):88-90. PubMed ID: 5422146
[No Abstract] [Full Text] [Related]
3. [Biotransformation of 9,9-dioxopromethazine (Prothanon)].
Borchert HH; Bornschein I; Pfeifer S; Kraft R
Pharmazie; 1977; 32(8-9):489-96. PubMed ID: 594113
[No Abstract] [Full Text] [Related]
4. [Biotransformation of 9.9-dioxopromethazine (Prothanon)].
Bornschein I; Pfeifer S
Pharmazie; 1972 Sep; 27(9):561-2. PubMed ID: 5086350
[No Abstract] [Full Text] [Related]
5. [Pharmaceutical analysis of 9,9-dioxopromethazine hydrochloride (Prothanon)].
Mayer W; Erbe S
Pharmazie; 1970 Feb; 25(2):84-7. PubMed ID: 5422145
[No Abstract] [Full Text] [Related]
6. [N-(2-hydroxyalkyloxy)-phthalimide. 1].
Kliegel W
Pharmazie; 1970 Jul; 25(7):400-3. PubMed ID: 5455429
[No Abstract] [Full Text] [Related]
7. [Metabolic drug interactions of 9,9-dioxopromethazine (prothanon)].
Borchert HH; Szołomicka-Orfinger I; Pfeifer S
Pharmazie; 1978 Oct; 33(10):686-7. PubMed ID: 724752
[No Abstract] [Full Text] [Related]
8. [The biotransformation of 9,9-dioxopromethazine (Prothanon)].
Bornschein I; Borchert HH; Pfeifer S
Pharmazie; 1973 Oct; 28(10):683-4. PubMed ID: 4783560
[No Abstract] [Full Text] [Related]
9. [The biotransformation of 9,9-dioxopromethazine (Prothanon)].
Borchert HH; Bornschein I; Pfeifer S
Pharmazie; 1976; 31(2):134-5. PubMed ID: 959258
[No Abstract] [Full Text] [Related]
10. [Decomposition of promethazine (Prothazin), promethazin sulfoxide and 9.9-dioxopromethazin (Prothanon)].
Bornschein I; Wünschmann H; Kraft R; Pfeifer S
Pharmazie; 1972 Sep; 27(9):555-60. PubMed ID: 4343761
[No Abstract] [Full Text] [Related]
11. [Derivatives of 4-hydroxy-1N-2,3-benzoxazine].
Pifferi G; Consonni P; Pasqualucci C; Testa E
Farmaco Sci; 1968 May; 23(5):477-89. PubMed ID: 5680387
[No Abstract] [Full Text] [Related]
12. [Chemical changes on the chanoclavin-(I) molecule].
Voigt R; Keipert S
Pharmazie; 1970 Jan; 25(1):54-63. PubMed ID: 5422129
[No Abstract] [Full Text] [Related]
13. Distribution, excretion, and metabolism of 14C-labeled quaternary ammonium salt of mepazine and promethazine in rats.
Huang CL; Yeh JA; Hsu SY
J Pharm Sci; 1970 Jun; 59(6):772-5. PubMed ID: 5463653
[No Abstract] [Full Text] [Related]
14. [Dihydroisoquinoline rearrangement. 13. Effect of substituents in the isoquinoline frame on the rearrangement of tertiary 1,2-dihydroisoquinolines].
Knabe J; Krause W; Powilleit H; Sierocks K
Pharmazie; 1970; 25(5):313-7. PubMed ID: 5455409
[No Abstract] [Full Text] [Related]
15. [A study of the stability of dioxopromethazine in aqueous solutions and ophthalmic instillation].
Capkova Z; Hudecová T; Hatrík S; Havránek E; Vitková Z
Ceska Slov Farm; 2004 Jul; 53(4):187-91. PubMed ID: 15369230
[TBL] [Abstract][Full Text] [Related]
16. [On the analysis of isoindoline derivatives. 2. Polarographic behavior of N-substituted nitroisoindolines].
Pflegel P; Hüttl G; Horsch W
Pharmazie; 1969 Apr; 24(4):203-8. PubMed ID: 5807368
[No Abstract] [Full Text] [Related]
17. [Oxidation of khellin by selenium dioxide].
Renzi G; Perini P
Farmaco Sci; 1969 Dec; 24(12):1073-81. PubMed ID: 5369333
[No Abstract] [Full Text] [Related]
18. [Change in the infrared absorption spectra of nystatin during its partial hydration].
Bol'shakova LO; Belen'kiĭ BG; Pokrovskiĭ EI
Antibiotiki; 1967 Oct; 12(10):884-7. PubMed ID: 5587854
[No Abstract] [Full Text] [Related]
19. [Study of ointments with antihistamincs. 1].
Rub-Saidac A; Bugnariu O; Filipas V; Ciocănelea V; Oprean I
Pharmazie; 1970 Mar; 25(3):194-6. PubMed ID: 4393873
[No Abstract] [Full Text] [Related]
20. [USE OF PHENOTHIAZINE AND ITS DERIVATIVES IN ANALYTICAL CHEMISTRY].
BLAZEK J
Pharmazie; 1963 Jun; 18():391-4. PubMed ID: 14061155
[No Abstract] [Full Text] [Related]
[Next] [New Search]
